In addition, inhibition of FASN (fatty acid synthase) can increase the expression of CD36 in cells, thereby increasing the proliferation of CRC cells, suggesting that the combination of inhibition of CD36 and increase of FASN expression can further increase the anti-cancer effect [19]. The gene discussed is CD36; the disease is colorectal carcinoma.